Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary hyperoxaluria type I.

K Latta1, J Brodehl

  • 1Kinderklinik der Medizinischen Hochschule, Abteilung für pädiatrische Nephrologie und Stoffwechselkrankheiten, Hannover, Federal Republic of Germany.

European Journal of Pediatrics
|May 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rheumatic joint disease in childhood and adolescence ].

Zeitschrift fur Rheumatologie·2012
Same author

[Rheumatic joint disease in childhood and adolescence].

Der Orthopade·2012
Same author

Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.

Kidney international·2006
Same author

Anuria during pneumoperitoneum in infants and children: a prospective study.

Journal of pediatric surgery·2005
Same author

Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients.

Clinical transplantation·2004
Same author

Long-term stable glomerular filtration rate achieved with tacrolimus in pediatric renal transplantation.

Transplantation proceedings·2002
Same journal

Cost-benefit analysis of nirsevimab for respiratory syncytial virus prevention in infants: a population-based study.

European journal of pediatrics·2026
Same journal

Consensus statement on the use of standardized early mobilization in pediatric patients admitted to pediatric intensive care units in Italy.

European journal of pediatrics·2026
Same journal

Ultrasound-guided midline catheters in the neonatal intensive care unit: a single-center pilot study.

European journal of pediatrics·2026
Same journal

Gastrointestinal pathogens in paediatric patients with diarrhoea during the COVID-19 pandemic in Spain: a multicentre molecular-based prospective study.

European journal of pediatrics·2026
Same journal

Low serum immunoglobulin levels in pediatric atopic dermatitis: association with disease severity and exploratory scores.

European journal of pediatrics·2026
Same journal

Safely developing respiratory care during emergency neonatal transport through systematic collection and analysis of detailed ventilator data.

European journal of pediatrics·2026
See all related articles

Primary hyperoxaluria type I, a genetic metabolic disorder, stems from deficient alanine:glyoxylate aminotransferase. Liver transplantation offers a metabolic correction, unlike kidney transplants which risk disease recurrence.

Area of Science:

  • Biochemistry
  • Genetics
  • Nephrology

Background:

  • Primary hyperoxaluria type I (PH I) is an inherited metabolic disorder.
  • It results from a deficiency in the peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT).
  • This deficiency leads to excessive oxalate production and deposition.

Purpose of the Study:

  • To outline the clinical course of PH I.
  • To review diagnostic strategies.
  • To discuss current and potential treatment modalities.

Main Methods:

  • Analysis of data from 330 published cases of PH I.
  • Review of diagnostic criteria including clinical parameters, urinary oxalate and glycolate levels, and liver enzyme activity.
  • Evaluation of treatment outcomes for conservative management, dialysis, and transplantation.

Related Experiment Videos

Main Results:

  • PH I is an autosomal recessive disorder with significant clinical variability.
  • Diagnosis relies on clinical findings, biochemical markers, and liver enzyme assays.
  • Conservative management includes hydration and pyridoxine; dialysis offers supportive care.
  • Kidney transplantation has a high recurrence rate and risk of graft loss.
  • Liver transplantation can correct the metabolic defect and halt disease progression.

Conclusions:

  • PH I management requires a multi-faceted approach.
  • Liver transplantation presents a promising option for metabolic correction in PH I.
  • Early diagnosis and intervention are crucial for managing this rare metabolic disorder.